Expression of cyclooxygenase-2 in malignant melanoma

Korean Journal of Dermatology

Volumn 43, Issue 1, 2005, Pages 15-21

  Jung, Do Sang ^a   Oh, Chang Keun ^a   Jang, Ho Sun ^a   Kim, Moon Bum ^a   Kwon, Kyung Sool ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Cyclooxygenase 2; Malignant melanoma

Indexed keywords

CYCLOOXYGENASE 2; PARAFFIN;

ARTICLE; BRESLOW THICKNESS; CANCER CLASSIFICATION; CANCER STAGING; CARCINOGENESIS; CLARK LEVEL; CLINICAL ARTICLE; CORRELATION COEFFICIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOCYTIC NEVUS; MELANOMA; PATHOLOGY; PROGNOSIS; PROTEIN EXPRESSION; SKIN BIOPSY;

EID: 14044258411     PISSN: 04944739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Moon SE, Cho KH, Hwang JH, Kim JA, Youn JI. A Statistical Study of cutaneous malignant tumors. Korean J Dermatol 1998;36:7-15
2. Harris RE, Kasbari S, Farrar WB. Prospective study of non-steroidal anti-inflammatory drugs and breast cancer. Oncol Rep 1999;6:71-73
3. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994;5:138-146
4. Campbell W, Halushka P. Lipid-derived autacoids: eicosanoids and platelet-activating factor. In: Hardman J, ed. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill Professional Book Group, 2001:669-686
5. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthase (cyclooxygenase)-1, -2. J Biol Chem 1996;271:33157-33160
6. Marnett LJ. Generation of Mutagens during arachinonic acid metabolism. Cancer Metastasis Rev 1994;13:303-308
7. Tsujii M, DuBios RN. Alternations in celluar adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;93:705-716
8. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-716
9. Chae SW, Sohn JH, Shin HS, Park YE. Expression of cyclooxygenase-2 protein in gastric carcinogenesis. Cancer Research and Treatment 2002;34:252-257
10. Denkert C, Kobel M, Berger S, Siegert A, Leclere A, Trefzer U et al. Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 2001;61:303-308
11. Subongkot S, Frame D, Leslie W, Drajer D. Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment. Pharmacotherapy 2003;23:9-28
12. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol 1997;24 Suppl 49:15-19
13. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000;69:145-182
14. Wiese FW, Thompson PA, Kadlubar FF. Carcinogen substrate specificity of human COX-1 and COX-2. Carcinogenesis 2001;22:5-10
15. Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y et al. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol 1998;274:G1061-1067
16. Moodycliffe AM, Nghiem D, Clydesdale G, Ullrich SE. Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol 2000;1:521-525
17. Goodwin JS, Ceuppens J. Regulation of the immune response by prostaglandins. J Clin Immunol 1983;3:295-315
18. Goodwin JS, Bankhurst AD, Messner RP. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell. J Exp Med 1977;146:1719-1734
19. Balch CM, Dougherty PA, Cloud GA, Tilden AB. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients. Surgery 1984;95:71-77
20. Kunkel SL, Wiggins RC, Chensue SW, Larrick J. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem Biophys Res Commun 1986;137:404-410
21. Kambayashi T, Alexander HR, Fong M, Strassmann G. Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10. J Immunol 1995;154:3383-3390
22. Stolina M, Sharma S, Lin Y, Dohadwala M, Gardner B, Luo J et al. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol 2000;164:361-370
23. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000;60:1306-1311
24. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000;105:1589-1594
25. Tomozawa S, Nagawa H, Tsuno N, Hatano K, Osada T, Kitayama J et al. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer 1999;81:1274-1279
26. Muller-Decker K, Reinerth G, Krieg P, Zimmermann R, Heise H, Bayerl C et al. Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin. Int J Cancer 1999;82:648-656